Xiao-ren H. Zhu
Zhenjiang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
PFDN5 synergizes with anti-PD1 therapy to promote triple-negative breast cancer cell death through JAK2/STAT3/c-Myc signaling axis.
Journal: Journal of translational medicine
Published: January 19, 2026
SPOCK1 acts as a negative regulator of ferroptosis in non-small cell lung cancer.
Journal: NPJ precision oncology
Published: July 21, 2025
Curcumin in colorectal cancer: mechanistic insights, pharmacological limitations, and translational perspectives.
Journal: Frontiers in pharmacology
Published: July 17, 2025
Identification of PRRG1 as a possible molecular target of pancreatic cancer.
Journal: Cell death & disease
Published: June 01, 2025
Characterization of ADGRG6 as a potential molecular oncotarget of pancreatic cancer.
Journal: Cell death & disease
Published: May 01, 2025
A novel immunological perspective on female-specific cancers: Exploring the signaling pathways of tertiary lymphoid structures and their clinical applications.
Journal: Life sciences
Published: February 18, 2025
PCK1 as a target for cancer therapy: from metabolic reprogramming to immune microenvironment remodeling.
Journal: Cell death discovery
Published: July 12, 2024
Identification of Gαi3 as a promising molecular oncotarget of pancreatic cancer.
Journal: Cell death & disease
Published: June 06, 2024
A novel identified epithelial ligand-receptor-associated gene signature highlights POPDC3 as a potential therapy target for non-small cell lung cancer.
Journal: Cell death & disease
Published: May 27, 2024
KCNAB2 overexpression inhibits human non-small-cell lung cancer cell growth in vitro and in vivo.
Journal: Cell death discovery
Published: July 25, 2023
Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer.
Journal: Cell death & disease
Published: November 03, 2022
Triptonide Inhibits the Cervical Cancer Cell Growth via Downregulating the RTKs and Inactivating the Akt-mTOR Pathway.
Journal: Oxidative medicine and cellular longevity
Published: August 05, 2022
Last Updated: 09/26/2026